AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Closed Loop Oxygen Control in INtubated Critically Ill Patients

RecruitingNAAges 18 Years - anyAllParc Taulí Hospital Universitari
💬

In plain words

What the trial is, and whether it could suit you

The deleterious effects of alveolar hyperoxia and (severe) hyperoxaemia are well described. Achieving safe and efficient oxygenation may be challenging. The hypothesis of the present study is that closed-loop oxygen control in intubated and mechanically ventilated critically ill patients improves oxygen administration compared with standard manual oxygen titrations. A single-blind, randomised crossover clinical trial assessing the efficacy and safety of the use of a closed-loop oxygen control versus manual oxygen titration in patients receiving mechanical ventilation has been designed. Patients will be randomised to receive first either closed-loop oxygen control (CLOC) or manual oxygen titration (MOT). The percentage of time spent in optimal and sub-optimal SpO2 (oxygen saturation by pulse oximetry) ranges will be calculated for each period.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Patients admitted to the ICU who are expected to require invasive mechanical ventilation for at least 8 hours and are expected to stay respiratory stable´ in the upcoming 8 hours. * Acute respiratory failure with PaO2/FiO2 \<300 with FiO2 ≥ 0.4 at inclusion * Age older than 18 years old. * Written informed consent signed and dated by the patient or one relative in case that the patient is unable to consent, after full explanation of the study by the investigator and prior to study participation. Exclusion Criteria: * Low quality on the SpO2 measurement using finger and ear sensor (quality index \<60%). * Hemodynamic instability defined as a need of continuous infusion of epinephrine or norepinephrine \> 1 mg/h. * Severe acidosis (pH ≤ 7.30). * Chronic or acute dyshemoglobinemia: methemoglobin, CO poisoning, sickle cell disease. * Patient under guardianship or deprived of liberties. * Impossibility to give informed consent by both patient and family (i.e. language barrier). * Patient included in another interventional research study under consent with similar outcome.
💊

What it tests

  • closed-loop oxygen control (CLOC)
  • 2. manual oxygen titration (MOT)
📍

Where

1 site
Parc Tauli Hospital Universitary
Sabadell, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy